References

Asahara, T., K. Shimizu, K. Nomoto, T. Hamabata, A. Ozawa and Y. Takeda, 2004. Probiotic bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157: H7. Infect. Immun., 72: 2240-2247.
CrossRef  |  Direct Link  |  

Bomba, A., R. Nemcova, D. Mudronova and P. Guba, 2002. The possibilities of potentiating the efficacy of probiotics. Trends Food Sci. Technol., 13: 121-126.
CrossRef  |  Direct Link  |  

Fioramonti, J., V. Theodorou and L. Bueno, 2003. Probiotics: What are they? What are their effects on gut physiology? Best Pract. Res. Clin. Gastroenterol., 17: 711-724.
PubMed  |  Direct Link  |  

Fooks, L.J. and G.R. Gibson, 2003. Mixed culture fermentation studies on the effects of synbiotics on the human intestinal pathogens Campylobacter jejuni and Escherichia coli. Anaerobe, 9: 231-242.
CrossRef  |  

Gagnon, M., E.E. Kheadr, G. Le Blay and I. Fliss, 2004. In vitro inhibition of Escherichia coli O157: H7 by bifidobacterial strains of human origin. Int. J. Food Microbiol., 92: 69-78.
CrossRef  |  

Gagnon, M., E.E. Kheadr, N. Dabour, D. Richard and I. Fliss, 2006. Effect of Bifidobacterium thermacidophilum probiotic feeding on enterohemorrhagic Escherichia coli O157: H7 infection in BALB/c mice. Int. J. Food Microbiol., 111: 26-33.
CrossRef  |  

Hajela, N., G.B. Nair, P. Abraham and N.K. Ganguly, 2012. Health impact of probiotics-vision and opportunities. Gut Pathogens, Vol. 4. 10.1186/1757-4749-4-1

Holzapfel, W.H., P. Haberer, R. Geisen, J. Bjorkroth and U. Schillinger, 2001. Taxonomy and important features of probiotic microorganisms in food and nutrition. Am. J. Clin. Nutr., 73: 365S-373S.
PubMed  |  Direct Link  |  

Isolauri, E., P.V. Kirjavainen and S. Salminen, 2002. Probiotics: A role in the treatment of intestinal infection and inflammation? Gut., 50: iii54-iii59.
Direct Link  |  

Kim, S.H., S.J. Yang, H.C. Koo, W.K. Bae and J.Y. Kim et al., 2001. Inhibitory activity of Bifidobacterium longum HY8001 against Vero cytotoxin of Escherichia coli O157: H7. J. Food Prot., 64: 1667-1673.
Direct Link  |  

Lema, M., L. Williams and D.R. Rao, 2001. Reduction of fecal sheeding of enterohermoraggic Escherichia coli O157:H7 in lambs by feeding microbial feed supplement. Small Ruminant Res., 39: 31-39.

Mirzaii, H., M.R. Nahaii, S.A. Taheri and S.A. Nakhjavani, 2010. Probiotics and introduction to their role in human health. J. Tabriz Univ. Med. Sci., 32: 80-85.

Molbak, K., P.S. Mead and P.M. Griffin, 2002. Antimicrobial therapy in patients with Escherichia coli O157: H7 infection. J. Am. Med. Assoc., 288: 1014-1016.
CrossRef  |  

Ouwehand, A.C., S. Salminen and E. Isolauri, 2002. Probiotics: An overview of beneficial effects. Antonie Van Leeuwenhoek, 82: 279-289.
PubMed  |  Direct Link  |  

Qi, H., Z. Zhong, H.X. Zhou, C.Y. Deng and H. Zhu et al., 2011. A rapid and highly sensitive protocol for the detection of Escherichia coli O157:H7 based on immunochromatography assay combined with the enrichment technique of immunomagnetic nanoparticles. Int. J. Nanomed., 6: 3033-3039.
CrossRef  |  Direct Link  |  

Shu, Q. and H.S. Gill, 2001. A dietary probiotic (Bifidobacterium lactis HN019) reduces the severity of Escherichia coli O157:H7 infection in mice. Med. Microbiol. Immunol., 189: 147-152.
CrossRef  |